Quercetin: Further investigation of its antinociceptive properties and mechanisms of action

Archives of Pharmacal Research

Volumn 31, Issue 6, 2008, Pages 713-721

  Filho, Arnaldo Willain ^a   Filho, Valdir Cechinel ^a   Olinger, Leonardo ^a   De Souza, Márcia Maria ^a  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

Author keywords

Antinociception; Flavonoid; Mechanisms of action; Mice; Quercetin; Sedative action

Indexed keywords

ACETIC ACID; ANALGESIC AGENT; CAPSAICIN; CHOLINERGIC RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; FORMALDEHYDE; GABAERGIC RECEPTOR AFFECTING AGENT; GLUTAMIC ACID; NARCOTIC ANALGESIC AGENT; NITRIC OXIDE SYNTHASE; QUERCETIN; SEROTONIN ANTAGONIST;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HEAT; MALE; METABOLISM; MOTOR ACTIVITY; MOUSE; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; REACTION TIME; SIGNAL TRANSDUCTION;

ACETIC ACID; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; CAPSAICIN; CHOLINERGIC AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FORMALDEHYDE; GABA AGENTS; GLUTAMIC ACID; HEAT; MALE; MICE; MOTOR ACTIVITY; NITRIC OXIDE SYNTHASE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; QUERCETIN; REACTION TIME; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION;

EID: 45749089003     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1217-2     Document Type: Article

References (43)

1. Anjaneyulu, M. and Chopra, K., Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. Indian J. Exp. Biol., 42, 766-769 (2004).
2. Beirith, A., Santos, A. R. S., and Calixto, J. B., Mechanism underlying the nociception and paw edema caused by injection of glutamate into the mouse paw. Brain Res., 924, 219-228 (2002).
3. Carter, G. T. and Sullivan, M. D., Antidepressants in pain management. Curr. Opin. Investig. Drug, 3, 454-458 (2002).
4. Cechinel Filho, V., Santos, A. R., De Campos, R. O., Miguel, O. G., Yunes. R. A., Ferrari, F., Messana, I., and Calixto, J. B., Chemical and pharmacological studies of Phyllanthus caroliniensis in mice. J. Pharm. Pharmacol., 48, 1231-1236 (1996).
5. Choi, S. S., Lee, J. K., and Suh, H. W., Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models. Brain Res., 921, 233-239 (2001).
6. Collier, H. D. J., Dinnin, L. C., Johnson, C. A., and Schneider, C., The abdominal response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol., 32, 295-310 (1968).
7. Comalada, M., Camuesco, D., Sierram S., Ballesterm I., Xausm J., Galvez. J., and Zarzuelo, A., In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappa B pathway. Eur. J. Immunol., 35, 584-592 (2005).
8. Eddy, N. B. and Leimbarck, D., Synthetic analgesics II. Dithienylbutenyl and dithienylbutylamines. J. Pharm. Exp. Ther., 107, 385-393 (1953).
9. B receptor agonist baclofen has non-specific antinociceptive effect in the model of peripheral neuropathy in the rat. Physiol. Res., 53, 351-355 (2004).
10. Hizue, M. A., Pang, C.A., and Yokoyama, M. B., Involvement of N-methyl-D-aspartate-type glutamate receptor [varepsilon]1 and [varepsilon]4 subunits in tonic inflammatory pain and neuropathic pain. Neuroreport., 16, 1667-1670 (2005).
11. Hunskaar, S., Fasmar, O. B., and Hole, K., Formalin test in mice: a useful technique for evaluating mild analgesics. J. Neurosci. Methods, 14, 69-76 (1985).
12. Hunskaar, S. and Hole, K., The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain, 30, 103-114 (1987).
13. Kauer, R., Singh, D, and Chopra, K., Participation of alpha2 receptors in the antinociceptive activity of quercetin. J. Med. Food, 4, 529-532 (2005).
14. Kris-Etherton, P. M., Lefevre, M., Beecher, G. R., Gross, M. D., Keen, C. L., and Etherton, T. D., Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu Rev. Nutr., 24, 511-538 (2004).
15. Kumazawa, T., Mizumura, K., Koda, H., and Fukusako, H. EP receptor subtypes implicate in the PGE2-induced sensitization of polymodal receptors in response to bradykinin and heat. J.Neurophysil., 75, 2361-2368 (1996).
16. Lee, B. H., Jeong, S. M., Lee, J. H., Kim, J. H., Yoon, I. S., Lee, J. H., Choi, S. H., Lee, S. M., Chang, C. G., Kim, H. C., Han, Y., Paik, H. D., Kim, Y., and Nah, S. Y., Quercetin inhibits the 5-hydroxytriptamine type 3 receptor-mediated ion current by interacting with pre-transmembrane domain I. Mol. Cells., 20, 60-73 (2005).
17. Liu, J., Yu, H., and Ning, X., Effect of quercetin on chronic enhancement of spatial learning and memory of mice. Scj. China C Life Sci., 49, 583-590 (2006).
18. Mackey, S. and Feinberg, S., Pharmacologic therapies for complex pain syndrome. Curr. Pain Headache Rep., 11, 38-43 (2007).
19. Manthey, J. A., Biological properties of flavonoids pertaining to inflammation. Microcirculation, 7, S29-S34 (2000).
20. Mantovani, M., Kaster, M. P., Pertile, R., Calixto, J. B., Rodrigues, A. L., and Santos, A. R., Mechanisms involved in the antinociception caused by melatonin in mice. J. Pineal Res., 41, 382-389 (2006).
21. Millan, M. J., Descending control of pain. Prog Neurobiol., 66, 355-474 (2002).
22. Moskaug, J. O., Carlsen, H., Myhrstad, M., and Blomhoff, R., Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech. Ageing Dev., 125, 315-324 (2004).
23. Murota, K. and Terao, J., Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys., 417, 12-17 (2003).
24. Naidu, P. S., Singh, A., and Kulkarni, S. K., D2-dopamine receptor and alpha2-adrenoreceptor-mediated analgesic response of quercetin. Indian J. Exp. Biol., 41, 1400-1404 (2003).
25. Neves, S. A., Freitas, A. L. P., Souza, B. W. S., Rocha M. L. A., Correia, M. V. O., Sampaio, D. A., and Viana, G. S. B., Antinociceptive properties in mice of a lectin isolated from the marine alga Amansia multifida Lamouroux. Braz. J. Med. Biol. Res., 40, 127-134 (2007).
26. Olszanecki, A., Gebska, A., Kozlovski, V. I., and Gryglewski, R. J., Flavonoids and nitric oxide synthase. J. Physiol. Pharmacol., 53, 571-584 (2002).
27. Okamoto, T., Safety of quercetin for clinical application. Int. J. Mol. Med., 16, 275-278 (2005).
28. Picq, M., Cheav, S. L., and Prigent, A. F., Effect of two flavonoid compounds on central nervous system: analgesic activity. Life Sci., 49, 1979-1988 (1991).
29. Riedel, W. and Neeck, G., Nociception, pain, and antinociception: current concepts. Z. Rheumatol., 60, 404-415 (2001).
30. Rodrigues, A. L, da Silva, G. L., Mateussi, A. S., Fernandes, E. S., Miguel, O. G., Yunes, R. A., Calixto, J. B., and Santos, A. R. S., Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci., 70, 1347-1358 (2002).
31. Rylski, M., Duriasz-Rowinska, H., and Rewerski, W., The analgesic action of some flavonoids in the hot-plate test. Acta Physiol. Pol., 30, 385-388 (1979).
32. Sakurada, T., Katsumata, K., Yogo, H., Tan-No, K., Sakurada, S., and Kisara, K., The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacol., 31, 1279-1285 (1992).
33. Sakurada, T., Katsumata, K., Yogo, H., Tan-No, K., Sakurada, S., and Kisara, K., Antinociception induced by CP96,345, a non-peptide NK1-receptor antagonist, in the mouse formalin and capsaicin tests. Neurosci. Letter., 151, 142-145 (1993).
34. Santos, A. R. S., PhD Thesis, UFSC, Florianópolis, Brazil, 2001.
35. Santos, A. R. S. and Calixto, J. B., Further evidence for the involvement of tachycinin receptor subtypes in formalin test and capsaicin models of pain in mice. Neuropeptides, 31, 381-389 (1997).
36. Santos A. R. S., Vedana, E. M., and De Freitas, G. A., Antinociceptive effect of meloxicam, in neurogenic and inflammatory nociceptive models in mice. Inflamm. Res., 47, 302-307 (1998).
37. Santos, A. R., Gadotti, V. M., Oliveira, G. L., Tibola, D., Paszcuk, A. F., Neto, A., Spindola, H.M. De Souza, M. M., Rodrigues, A. L., and Calixto, J. B. Mechanisms involved in the anti-nociception caused by agmatine in mice. Neuropharmacol., 48, 1021-1034 (2005).
38. Schultke, E., Kendall, E., Kamencic, H., Ghong, Z., Griebel, R. W., and Juurlink B. H., Quercetin promotes functional recovery following acute spinal cord injury. J. Neurotrauma, 20, 583-591 (2003).
39. Theoharides, T. C., Treatment approaches for painful bladder syndrome/interstitial cystitis. Drugs, 6, 215-235 (2007).
40. Thomasset, S. C., Berry, D. P., Garcea, G., Marczylo, T., Steward, W. P., and Gescher, A. J., Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties. Int. J. Cancer, 120, 451-458 (2007).
41. Toker, G., Kupeli, E., Memisoglu, M., and Yesilada, E., Flavonoids with antinociceptive and anti-inflammatory activities from the leaves of Tilia argentea (silver linden). J. Ethnopharmacol., 95, 393-399 (2004).
42. Zimmermann, M., Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16, 109-110 (1983).
43. Yashpal, K., Fisher, K., Chabot, J. G., and Coderre, T. J., Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats. Pain, 94, 17-29 (2001).